Loading insider details...
Latest Form 4 (Nov 13, 2026): Grant/Award of 164,790 OBX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Obsidian Therapeutics, Inc. (OBX) | Grant/Award | 164,790 | n/a |
| Oct 21, 2024 | Aura Biosciences, Inc. (AURA) | Exercise/Conversion | 17,500 | $48.0K |
| Feb 2, 2024 | Aura Biosciences, Inc. (AURA) | Grant/Award | 71,285 | n/a |
| Jan 24, 2024 | Aura Biosciences, Inc. (AURA) | Sale | 6,609 | $50.5K |
| Nov 7, 2023 | Aura Biosciences, Inc. (AURA) | Exercise/Conversion | 3,900 | $10.7K |
| Nov 1, 2023 | Aura Biosciences, Inc. (AURA) | Sale | 3,385 | $23.1K |
| Jan 23, 2023 | Aura Biosciences, Inc. (AURA) | Grant/Award | 48,750 | n/a |
| Nov 3, 2022 | Aura Biosciences, Inc. (AURA) | Sale | 2,015 | $25.1K |
| Oct 29, 2021 | Aura Biosciences, Inc. (AURA) | Grant/Award | 26,250 | n/a |